-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly executives say the company currently accounts for more than 30% of the new prescriptions in the oral obesity treatment market.

智通财经·09/14/2026 18:17:11
语音播报
Eli Lilly executives say the company currently accounts for more than 30% of the new prescriptions in the oral obesity treatment market.